Representative before the EPO

Employment test 11 - 50 employees
Company dna gill jennings and every llp
operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

Robert Edward Perry has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11183830

The therapeutic use of tetrathiomolybdate

IPC classification:
A61K 33/24, A61P 9/10
Agent:
Robert Edward Perry, Gill Jennings & Every LLP
Status:
APPLICATION REFUSED
EP12188047

Use of amisulpride for treating chemotherapy-induced nausea and vomiting

IPC classification:
A61K 9/00, A61K 31/282, A61K 31/40, A61K 31/4178, A61K 31/485, A61K 47/12, A61P 1/08
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12189630

Tetrathiomolybdate for use in the treatment of ischemia-reperfusion injury of the heart

IPC classification:
A61K 33/24, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11716626

TETRATHIOMOLYBDATE FOR USE IN THE TREATMENT OF ISCHEMIA-REPERFUSION INJURY OF THE HEAD OR BRAIN

IPC classification:
A61K 33/24, A61P 7/04, A61P 9/00, A61P 9/10, A61P 41/00, A61P 43/00
Applicant:
University College London
Agent:
Multiple attorneys, Gill Jennings & Every LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature